Katrin A. Salva

798 total citations
18 papers, 464 citations indexed

About

Katrin A. Salva is a scholar working on Dermatology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Katrin A. Salva has authored 18 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Dermatology, 9 papers in Pathology and Forensic Medicine and 7 papers in Oncology. Recurrent topics in Katrin A. Salva's work include Cutaneous lymphoproliferative disorders research (10 papers), Lymphoma Diagnosis and Treatment (7 papers) and Vascular Tumors and Angiosarcomas (3 papers). Katrin A. Salva is often cited by papers focused on Cutaneous lymphoproliferative disorders research (10 papers), Lymphoma Diagnosis and Treatment (7 papers) and Vascular Tumors and Angiosarcomas (3 papers). Katrin A. Salva collaborates with scholars based in United States, Germany and France. Katrin A. Salva's co-authors include Gary S. Wood, Joachim Dissemond, Uwe Wollina, Sven Benson, Finja Jockenhöfer, Youn H. Kim, Seema Nagpal, Uma Sundram, Mahkam Tavallaee and Shufeng Li and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gut.

In The Last Decade

Katrin A. Salva

17 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katrin A. Salva United States 11 305 216 191 110 71 18 464
Giorgio Filosa Italy 13 382 1.3× 189 0.9× 229 1.2× 107 1.0× 361 5.1× 33 786
François Comoz France 11 115 0.4× 122 0.6× 111 0.6× 111 1.0× 61 0.9× 23 405
Aikaterini Zioga Greece 9 121 0.4× 126 0.6× 105 0.5× 126 1.1× 80 1.1× 23 426
Ariënne M. W. Van Marion Netherlands 12 277 0.9× 172 0.8× 236 1.2× 114 1.0× 37 0.5× 25 466
Barbara Giomi Italy 15 165 0.5× 323 1.5× 129 0.7× 19 0.2× 224 3.2× 36 740
Connie A. Keehn United States 11 178 0.6× 117 0.5× 116 0.6× 258 2.3× 40 0.6× 20 453
Allireza Alloo United States 12 284 0.9× 78 0.4× 218 1.1× 112 1.0× 59 0.8× 23 532
Carl V. Washington United States 13 311 1.0× 70 0.3× 245 1.3× 289 2.6× 13 0.2× 28 571
Jaime Eduardo Calonje United Kingdom 9 142 0.5× 65 0.3× 90 0.5× 163 1.5× 31 0.4× 15 387
C. Guillén-Barona Spain 12 161 0.5× 46 0.2× 151 0.8× 113 1.0× 18 0.3× 26 307

Countries citing papers authored by Katrin A. Salva

Since Specialization
Citations

This map shows the geographic impact of Katrin A. Salva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrin A. Salva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrin A. Salva more than expected).

Fields of papers citing papers by Katrin A. Salva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrin A. Salva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrin A. Salva. The network helps show where Katrin A. Salva may publish in the future.

Co-authorship network of co-authors of Katrin A. Salva

This figure shows the co-authorship network connecting the top 25 collaborators of Katrin A. Salva. A scholar is included among the top collaborators of Katrin A. Salva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katrin A. Salva. Katrin A. Salva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Jockenhöfer, Finja, Uwe Wollina, Katrin A. Salva, Sven Benson, & Joachim Dissemond. (2019). The PARACELSUS score: a diagnostic tool for pyoderma gangrenosum. British Journal of Dermatology. 180(3). 1 indexed citations
2.
Salva, Katrin A., Youn H. Kim, Ziba Rahbar, & Gary S. Wood. (2018). Epigenetically Enhanced PDT Induces Significantly Higher Levels of Multiple Extrinsic Pathway Apoptotic Factors than Standard PDT , Resulting in Greater Extrinsic and Overall Apoptosis of Cutaneous T‐cell Lymphoma. Photochemistry and Photobiology. 94(5). 1058–1065. 10 indexed citations
3.
Jockenhöfer, Finja, Uwe Wollina, Katrin A. Salva, Sven Benson, & Joachim Dissemond. (2018). The PARACELSUS score: a novel diagnostic tool for pyoderma gangrenosum. British Journal of Dermatology. 180(3). 615–620. 92 indexed citations
4.
Corbin, Zachary, Shufeng Li, Ziba Rahbar, et al.. (2017). Characterization of the peripheral neuropathy associated with brentuximab vedotin treatment of Mycosis Fungoides and Sézary Syndrome. Journal of Neuro-Oncology. 132(3). 439–446. 27 indexed citations
5.
Jockenhöfer, Finja, Tobias Schimming, Jörg Schaller, et al.. (2017). Sebaceous tumours: more than skin deep. Gut. 67(11). 1957–1957. 2 indexed citations
6.
Placke, Jan‐Malte, et al.. (2017). Dermatomyositis and lung cancer. QJM. 111(3). 195–195.
7.
Salva, Katrin A., et al.. (2016). c-CBL E3 Ubiquitin Ligase Expression Increases Across the Spectrum of Benign and Malignant T-Cell Skin Diseases. American Journal of Dermatopathology. 39(10). 731–737. 3 indexed citations
8.
Salva, Katrin A. & Gary S. Wood. (2015). Epigenetically Enhanced Photodynamic Therapy ( e PDT ) is Superior to Conventional Photodynamic Therapy for Inducing Apoptosis in Cutaneous T‐Cell Lymphoma. Photochemistry and Photobiology. 91(6). 1444–1451. 11 indexed citations
9.
Salva, Katrin A., Daniel Bennett, Jack Longley, Joan Guitart, & Gary S. Wood. (2015). Multispectral Imaging Approach to the Diagnosis of a CD20+ Cutaneous T-cell Lymphoproliferative Disorder. American Journal of Dermatopathology. 37(10). e116–e121. 6 indexed citations
10.
Kim, Youn H., Mahkam Tavallaee, Uma Sundram, et al.. (2015). Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project. Journal of Clinical Oncology. 33(32). 3750–3758. 183 indexed citations
11.
Wu, Jianqiang, Katrin A. Salva, & Gary S. Wood. (2014). c-CBL E3 Ubiquitin Ligase Is Overexpressed in Cutaneous T-Cell Lymphoma: Its Inhibition Promotes Activation-Induced Cell Death. Journal of Investigative Dermatology. 135(3). 861–868. 17 indexed citations
12.
13.
Wu, Jianqiang, Katrin A. Salva, Nathalie Stutz, et al.. (2014). Quantitative gene analysis of methylation and expression (Q‐GAME) in fresh or fixed cells and tissues. Experimental Dermatology. 23(5). 304–309. 11 indexed citations
14.
Salva, Katrin A., Anna Haemel, Laura B. Pincus, et al.. (2013). Expression of CD31/PECAM-1 (Platelet Endothelial Cell Adhesion Molecule 1) by Blastic Plasmacytoid Dendritic Cell Neoplasms. JAMA Dermatology. 150(1). 73–73. 10 indexed citations
15.
Gandhi, Mitul, Andrew M. Evens, Timothy S. Fenske, et al.. (2013). Pancreatitis In Patients Treated With Brentuximab Vedotin: A Previously Unrecognized Serious Adverse Event. Blood. 122(21). 4380–4380. 7 indexed citations
16.
Salva, Katrin A., et al.. (2013). Possible Association of Cutaneous Rosai-Dorfman Disease and Chronic Crohn Disease. JAMA Dermatology. 150(2). 177–177. 11 indexed citations
17.
Krathen, Michael, Uma Sundram, Katherine Sutherland, et al.. (2012). Brentuximab Vedotin Demonstrates Significant Clinical Activity in Relapsed or Refractory Mycosis Fungoides with Variable CD30 Expression. Blood. 120(21). 797–797. 19 indexed citations
18.
Salva, Katrin A.. (2002). Photodynamic therapy: unapproved uses, dosages, or indications. Clinics in Dermatology. 20(5). 571–581. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giorgio Filosa Breakdown of academic impact, for papers by François Comoz Breakdown of academic impact, for papers by Aikaterini Zioga Breakdown of academic impact, for papers by Ariënne M. W. Van Marion Breakdown of academic impact, for papers by Barbara Giomi Breakdown of academic impact, for papers by Connie A. Keehn Breakdown of academic impact, for papers by Allireza Alloo Breakdown of academic impact, for papers by Carl V. Washington Breakdown of academic impact, for papers by Jaime Eduardo Calonje Breakdown of academic impact, for papers by C. Guillén-Barona
Rankless by CCL
2026